RecruitingNCT04344119

Assessment of Chilbains Occuring During Covid-19 Infection

Assessment of Skin Manifestations Occuring During Covid-19 Infection With a Special Focus on Chilbains


Sponsor

Centre Hospitalier Universitaire de Nice

Enrollment

30 participants

Start Date

Apr 9, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

Some patients infected by covid-19 develop skin manifestations. These manifestations are still not well known and there pathophysiology remain unclear. Among them, acral manifestation resembling to chilblains appears frequent and quite specific. The aim of this project is to better characterize the cutaneous manifestations occurring during Covid-19 infection with a special focus on chilblains. These acral manifestation could be due to a direct viral effect, but also to microthrombosis or vascularitis. Understanding the pathomechanisms involved could provide interesting clue for understanding not only the skin manifestations but also some of the other systemic symptoms associated to covid-19 infection. This study plan to characterize these acral manifestations by analyzing the clinical and dermoscopic patterns and to correlate them with the non-invasive vascular explorations but also immune and coagulopathy explorations that are done in the CHU of Nice in covid-19 patients.


Eligibility

Max Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with covid, chilblains, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include up to age 90 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

CHU de Nice

Nice, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04344119


Related Trials